People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

6 Dec 2019
Change (% chg)

$-0.03 (-0.81%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Patel, Gautam 

Mr. Gautam Patel is Director of the Company. Mr. Patel has been Managing Director of Tarsadia Investments, a private investment firm based in Newport Beach, California, since 2012. In that role, Mr. Patel has led a team of investment professionals to identify, evaluate and execute principal control over equity investments across sectors including life sciences, financial services and technology. Prior to joining Tarsadia, Mr. Patel served as Managing Director at Lazard from 2008 to 2012, where he led financial and strategic advisory efforts in sectors including transportation and logistics, private equity, and healthcare. Prior to that, Mr. Patel served in a variety of advisory roles at Lazard from 1999 to 2008, including multiple restructuring, bankruptcy and corporate reorganization assignments in 2001 and 2008. From 1994 to 1997, Mr. Patel was an Analyst at Donaldson, Lufkin & Jenrette, where he worked on mergers & acquisitions as well as high-yield and equity financings. Mr. Patel is currently a Board Member of several private companies such as Adello Biologics, Asana Biosciences, LERETA, Envisics and AIONX Antimicrobial Technologies. Mr. Patel also serves on the boards of Tarsadia Foundation and Casita Maria Center for Arts & Education, a New York based non-profit organization which aims to empower children through arts based education. Mr. Patel received a BA from Claremont McKenna College, a BS from Harvey Mudd College, an MSc from the London School of Economics and an MBA from the University of Chicago.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 91,667
Long-Term Incentive Plans, USD --
All Other, USD 240,000
Fiscal Year Total, USD 331,667

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --